Category: Posters

2018

  • Pradelli L, Zaniolo O, Diamanti A, Agostoni C, Lezo A. Be aware of pediatric malnutrition at admission! Economic consequences of different hospital screening and nutritional treatment approaches. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Bellone M, Pradelli L, Recchia A, Caputo A, Masetti L. Budget impact analysis of alectinib for the treatment of patients with untreated ALK-rearranged NSCLC in Italy. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Povero M, Pradelli L1, Pinciroli M. Cost–utility of surgical sutureless bioprostheses vs. Tavi in aortic valve replacement for patients at intermediate and high surgical risk. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Bellone M, Pradelli L, Masetti L, Recchia A, Orfanos P. Cost-effectiveness analysis of alectinib in untreated ALK-rearranged NSCLC Italian patients. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Pradelli L, Zaniolo O, Caputo A, Roussel M, Tournier C. Cost-utility analysis of adjuvant pertuzumab-based regimen in women with HER2-positive breast cancer in Italy. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Bellone M, Pradelli L, Recchia A, Gervasi A, Orfanos P. Cost-utility analysis of tocilizumab in combination with corticosteroids for the treatment of giant cell arteritis in Italian patients. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Povero M, Dal Negro RW, Turco P. Patients’ usability of six most used dry-powder inhalers in asthma and COPD. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Bellone M, Pradelli L, Povero M, Lezo A, De Francesco A, Plazzotta C, Ferraris R, Pezzana A. Past, current and expected need for home artificial nutrition in Piedmont: resources needed to maintain a recognized high quality level. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018
  • Bellone M, Pradelli L, Recchia A, Gervasi A. Tocilizumab in combination with corticosteroids for the treatment of giant cell arteritis: a budget impact analysis in Italy. ISPOR 21th Annual European Congress, Barcelona, Spain, November, 2018

2017

  • Povero M, Pradelli L. Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for The Treatment of Schizophrenia In Italy. ISPOR 20th Annual European Congress, Glasgow, Scotland, 4-8 November, 2017
  • Villa S, Castaman G, Pradelli L. Idelvion For The Treatment of Hemophilia B: A Budget Impact Analysis In The Italian Setting. ISPOR 20th Annual European Congress, Glasgow, Scotland, 4-8 November, 2017

2016

  • Pradelli L, Ghetti G. A General Model for the Estimation of Societal Costs of Lost Production and Informal Care in Italy. ISPOR 19th Annual European Congress, Vienna, Austria, 29 October-2 November, 2016
  • Pradelli L, Povero M, Myers G. Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery: A Network Meta-Analysis of Randomized Controlled Trials. ISPOR 19th Annual European Congress, Vienna, Austria, 29 October-2 November, 2016
  • Pradelli L, Graf S, Ehm A., Fries-Schaffner E, Pichard C, Berger M. Cost-Effectiveness of the Swiss Supplemental Parenteral Nutrition (Spn) Intervention. ESPEN 38th Congress, Copenhagen, Denmark, 17-20 September, 2016

2015

  • Pradelli L, Bellone M, Zaniolo O. Development of MS Budget Manager: a Practical Tool to Assist Alternative Stakeholders at Multiple Decision Levels in the Forecast and Financial Management for Multiple Sclerosis (MS). ISPOR 18th Annual European Congress, Milan, Italy, 7-11 November, 2015
  • Pradelli L, Bellone M, Era S, Campagnoli E. Cost-Effectiveness Analysis of Neo-Adjuvant Pertuzumab Therapy in Women With Locally Advanced, Inflammatory, or Early Her2-Positive Breast Cancer in Italy. ISPOR 18th Annual European Congress, Milan, Italy, 7-11 November, 2015
  • Povero M, Pradelli L. Biologic Treatments for Moderate to Severe Naïve Psoriatic Patients: A Budget Impact Analysis in Italy. ISPOR 18th Annual European Congress, Milan, Italy, 7-11 November, 2015
  • Eandi M, Marasca S, Povero M, D’Andrea A, Tieghi A, Randi V, Picardi F, Gandini G, Aprili G, Piani M,Velati C. Alla ricerca dell’efficienza nella plasmaferesi: un confronto tra strutture. SIMTI IV Conferenza Nazionale dei Servizi Trasfusionali, Naples, Italy, 28-30 May, 2015
  • L Pradelli, A Feuersenger, A Aliano, JF Baron, M Westphal. Short Term Sedation of Mechanically Ventilated ICU Patients With Propofol, Benzodiazepines, or Dexmedetomidine: Systematic Review and Meta-Analysis on Awakening and Recovery Times. ISICEM 35th International Symposium, Brussels, Belgium, 17-20 March, 2015

2014

  • Zaniolo O, Povero M, Pradelli L, Pizzorno B, Mancini N. An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time PCR-Based Assay in Patients With Suspected Sepsis. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Hashim MS, Povero M, Aliano A, Pradelli L. Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; the French Context ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Povero M, Pradelli L. Goal Directed Perfusion (GDP): a Differential Cost Analysis in UK and US. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Budget Impact Analysis of Apixaban Versus other Noacs for the Prevention of Stroke in Italian non-Valvular Atrial Fibrillation Patients. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Cost Effectiveness Analysis of Apixaban Versus Other Noacs for the Prevention of Stroke in Italian non-Valvular Atrial Fibrillation Patients. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Pharmacoeconomic Assessment of Apixaban Versus Standard of Care for the Prevention of Stroke in Italian non-Valvular Atrial Fibrillation Patients. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Eandi M, Pradelli L, Della Pepa C, Povero M. Discrete Event Simulation of Haemophilia A Real-Life Management Strategies With FVIII: Integrating PK/PD, Epidemiology, Clinical Evidence, and Cost-Effectiveness Analysis. 17th World Congress of Pharmacology, Cape Town, South Africa, 13-18 July, 2014

2013

  • Povero M, Pradelli L, Bonadiman L, Dal Negro RW. Cost and Cost-effectiveness Analyses for Moderate and Severe COPD Patients Treated Uniquely With Tiotropium 18 mcg OD for Twenty-Four Months. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Povero M, Pitrelli A, Pradelli L. How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated With 5alpha-Reductase Inhibitors. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Giardina S, Ranucci M.
  • Lifetime Outcomes and Costs of Concomitant Aortic Valve Replacement in France and UK: the Performance of a Sutureless and Collapsed Valve. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Giardina S, Ranucci M. Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in Germany. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Giardina S, Ranucci M. Lifetime Cost-Effectiveness of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a new Sutureless and Collapsed Valve in France and UK. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Povero M, Pradelli L. Potential Financial Impact of Sugammadex in Anaesthetic Departments: a Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar Blockade. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Zaniolo O, Povero M, Gandini G, Aprili G, Eandi M. Full Cost of Plasma From Voluntary non Remunerated Donors in Italy. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Zaniolo O, Muscaritoli M, Eandi M. Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients. ESPEN 35th congress, Leipzig, Germany, 31 August – 3 September, 2013 (Abstract’s Content View)
  • Pradelli L, Povero M. Potential of Omega-3 Fatty Acid in Parenteral Nutrition in Germany: a Budget Impact Analysis. ESPEN 35th Congress, Leipzig, Germany, 31 August – 3 September, 2013 (Abstract’s Content View)

2012

  • Hu SL, Pradelli L, Luo L, Liu F, Kulkarni H, Dai Y. A Discrete Event Simulation Model Used for Pharmacoeconomic Evaluation of Omegaven® in the Chinese Setting. ISPOR 15th Annual European Congress, Berlin, Germany, November, 2012
  • Zaniolo O, Povero M, Pradelli L. Budget Impact of Backbone Choice in Italian Treatment- Naive, HIV-Infected Patients. ISPOR 15th Annual European Congress, Berlin, Germany, November, 2012
  • Pradelli L, Eandi M, Povero M, Mayer K, Heller AR, Muscaritoli M. Cost-Effectiveness of Supplemental N-3 in Total Parenteral Nutrition Therapy in the Italian, French, German and UK Context: a Discrete Event Simulation Model. ISPOR 15th Annual European Congress, Berlin, Germany, November, 2012
  • Pradelli L, Zaniolo O, Giardina S, Ranucci M. Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Suturless and Collapsed Valve in Italy, France, Germany, and UK. ISPOR 15th Annual European Congress, Berlin, Germany, November, 2012

2011

  • Zaniolo O, Bettoncelli G, Bosio G, Mantovani LG, Pistelli R, Vaghi A, Villa M, Iannazzo S, Bamfi F, Pitrelli A, Frizzo V, Dal Negro RW. How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost? ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
  • Iannazzo S, Didoni G, Crocchiolo D. A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy. ISPOR 14th Annual European Congress, Madrid, Spain November, 2011
  • Paggiaro P, Buseghin G, Nicolini G, Patel S, Iannazzo S, Zaniolo O, Papi A. The Cost-Effectiveness of Step Down From High Dose ICS/LABA Combination Therapy in Asthma in the UK Setting. ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
  • Iannazzo S, Pradelli L, Montagnoli R, Militano L. Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients With Hyperglycaemia in Italy. ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011
  • Iannazzo S, Pradelli L, Chiroli S, Pétavy F, Briggs A. A Simulation Model of the Effects of Treatments for Secondary Hyperparathyroidism on Mortality. ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011

2010

  • Zaniolo O, Pradelli L. Economic Performance of Dabigatran Etexilate for Primary VTE Prevention Following Total Hip and Knee Replacement Surgery in Italy. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Iannazzo S, Pradelli L, Chiroli S. A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism (SHPT) in Five European Countries. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Iannazzo S, Zaniolo O, Giuliani G. A Budget Impact Model for the Economic Assessment of Tocilizumab in the Treatment of Rheumatoid Arthritis Patients in Italy. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Zaniolo O, Iannazzo S, Carsi M. A Cost-Utility Analysis for Tiotropium in the Long Term Treatment of Specific Subgroups of Italian COPD Patients. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Pradelli L, Zaniolo O, Iannazzo S, Eandi M. Parenteral Alanyl-Glutammine in Critically Ill Patients: a Bayesian Meta-Analysis of Published Trials. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Zaniolo O, Carsi M, Patrucco GP, Bellini R. Clinical and Economic Outcomes of Ziconotide Neuromodulation in Italian Cancer Patients. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010
  • Iannazzo S, Zaniolo O, Carsi M. Pharmacoeconomic Evaluation of Tiotropium Bromide in the Long Term Treatment of COPD in Italy. ECHE, 8th European Conference on Health Economics, Helsinki, Finland, 7-10 July, 2010 (Poster n. 137)
  • Iannazzo S, Pradelli L, Chiroli S, Pontoriero G, Eandi M. A Cost-Utility Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism (SHPT): Consistent Results in Three European Countries. XLVII ERA-EDTA CONGRESS, Munich, Germany, 25-28 June, 2010,

2009

  • Eandi M, Pradelli L, Iannazzo S. Alanyl-Glutamine Dipeptide (Dipeptiven®) in Total Parenteral Nutrition (TPN) Therapy in Critically Ill Italian Patients: a Pharmacoeconomic Simulation Model. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S, Pradelli L, Perachino M. Cost-Effectiveness Analysis of Hormonal Therapies in Patients With Advanced Prostate Cancer in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S, Sacchi V. A Pharmacoeconomic Evaluation of Influenza Vaccination in the Elderly Population in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S , Zaniolo O, Botrugno P. Survey on the Management of Oral Anticoagulation Therapy (Oat) in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Dal Negro RW, Pradelli L, Micheletto C, Tognella S, Iannazzo S. Add-on Omalizumab in Persistent Difficult-to-Treat Asthma: a 12-Month Study on Clinical, Economic Outcomes and Related Cost/Utility. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Eandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. A Patient-Level Simulation Model for Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism (SHPT) in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009